
David Hou Awarded 2022 ABTA Lucien Rubinstein Award for ‘B Cell Vaccine Promotes Anti-Glioma Immunity Through Modulating CD8+ T Cells’
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
Kaitlin Stitz is awarded for her research on overcoming radioresistance in treatment of high risk pediatric tumors, which she conducted during her ABTA Medical Student Summer Fellowship.
The need for better brain tumor treatments is greater than ever. That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
The ABTA has been a top resource for brain tumor educational materials for over 50 years. All of our educational brochures are carefully reviewed by brain tumor medical experts, and brain tumor patients and caregivers.. These brochures are 100% free for patients and caregivers.
Donating to the ABTA is a meaningful way to recognize someone whose life has been impacted by a brain tumor. With your gift, you can honor key milestones in a brain tumor survivor’s life, or convey the sense of loss when a friend or loved one loses their battle with this disease.